CAMAIONI, Emidio
 Distribuzione geografica
Continente #
NA - Nord America 5.176
EU - Europa 3.724
AS - Asia 3.566
SA - Sud America 602
Continente sconosciuto - Info sul continente non disponibili 419
AF - Africa 90
OC - Oceania 2
Totale 13.579
Nazione #
US - Stati Uniti d'America 5.046
SG - Singapore 1.681
UA - Ucraina 674
IE - Irlanda 614
IT - Italia 602
RU - Federazione Russa 500
CN - Cina 498
BR - Brasile 461
HK - Hong Kong 457
VN - Vietnam 297
DE - Germania 280
SE - Svezia 264
FI - Finlandia 201
FR - Francia 201
GB - Regno Unito 132
TR - Turchia 108
KR - Corea 97
BD - Bangladesh 91
IN - India 87
PL - Polonia 58
CA - Canada 52
AR - Argentina 48
MX - Messico 41
NL - Olanda 34
IQ - Iraq 33
JP - Giappone 30
CO - Colombia 28
CH - Svizzera 27
UZ - Uzbekistan 26
BE - Belgio 23
ID - Indonesia 22
PK - Pakistan 22
AT - Austria 21
CZ - Repubblica Ceca 20
ES - Italia 19
ZA - Sudafrica 17
VE - Venezuela 16
EC - Ecuador 15
PH - Filippine 14
EG - Egitto 13
CL - Cile 12
GR - Grecia 12
JM - Giamaica 12
MA - Marocco 12
RO - Romania 12
TN - Tunisia 12
AZ - Azerbaigian 11
JO - Giordania 11
LB - Libano 10
PY - Paraguay 10
LT - Lituania 9
SA - Arabia Saudita 9
IL - Israele 8
MY - Malesia 7
NP - Nepal 7
SV - El Salvador 7
EU - Europa 6
OM - Oman 6
CR - Costa Rica 5
DZ - Algeria 5
KZ - Kazakistan 5
LY - Libia 5
PE - Perù 5
AE - Emirati Arabi Uniti 4
BG - Bulgaria 4
BO - Bolivia 4
ET - Etiopia 4
KE - Kenya 4
PA - Panama 4
AM - Armenia 3
HN - Honduras 3
PT - Portogallo 3
SN - Senegal 3
TH - Thailandia 3
BH - Bahrain 2
CI - Costa d'Avorio 2
DK - Danimarca 2
IR - Iran 2
KG - Kirghizistan 2
KW - Kuwait 2
NE - Niger 2
NG - Nigeria 2
NO - Norvegia 2
PR - Porto Rico 2
PS - Palestinian Territory 2
TM - Turkmenistan 2
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
AU - Australia 1
AW - Aruba 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BN - Brunei Darussalam 1
BW - Botswana 1
BY - Bielorussia 1
DO - Repubblica Dominicana 1
GA - Gabon 1
GH - Ghana 1
GY - Guiana 1
HU - Ungheria 1
Totale 13.145
Città #
Singapore 1.127
Dublin 609
Chandler 556
San Jose 526
Hong Kong 452
Jacksonville 409
San Mateo 336
Ashburn 294
Santa Clara 221
Boardman 214
Perugia 193
Moscow 173
Altamura 165
Medford 156
Princeton 154
Lauterbourg 140
Beijing 125
Dong Ket 119
Lawrence 105
Wilmington 104
Ann Arbor 97
Seoul 97
Los Angeles 88
Munich 87
Andover 86
Izmir 77
New York 75
The Dalles 61
Redmond 58
Des Moines 56
Ho Chi Minh City 51
Saint Petersburg 49
São Paulo 43
Hanoi 41
Piscataway 39
Helsinki 35
Dallas 28
Orem 27
Turku 27
Chicago 25
Tokyo 25
London 23
Norwalk 23
Rome 22
Brussels 21
San Paolo di Civitate 21
Brooklyn 20
Montreal 20
Denver 19
Woodbridge 19
Chennai 18
Mexico City 18
Nuremberg 18
Phoenix 18
Shanghai 17
Tashkent 17
San Francisco 16
Warsaw 16
Baghdad 15
Boston 15
Houston 15
Milan 14
Poplar 14
Rio de Janeiro 14
Atlanta 13
Johannesburg 13
Ankara 12
Charlotte 12
Stockholm 12
Belo Horizonte 11
Bucharest 11
Buffalo 11
Den Haag 11
Haiphong 11
Manchester 11
Redwood City 11
Auburn Hills 10
Amsterdam 9
Baku 9
Medellín 9
Toronto 9
Zhengzhou 9
Amman 8
Annapolis 8
Bogotá 8
Council Bluffs 8
Falls Church 8
New Delhi 8
Olomouc 8
San Diego 8
Tianjin 8
Brno 7
Cairo 7
Hefei 7
Krakow 7
Quito 7
Seattle 7
Bologna 6
Brasília 6
Casablanca 6
Totale 8.089
Nome #
Advances in indoleamine 2,3-dioxygenase 1 medicinal chemistry 182
Computational studies in enantioselective liquid chromatography: Forty years of evolution in docking- and molecular dynamics-based simulations 162
Critical Assessment of a Structure-Based Screening Campaign for IDO1 Inhibitors: Tips and Pitfalls 137
Biochemical Studies on Human Ornithine Aminotransferase Support a Cell-Based Enzyme Replacement Therapy in the Gyrate Atrophy of the Choroid and Retina 135
3alpha-6alpha-Dihydroxy-7alpha-fluoro-5beta-cholanoate (UPF-680), physicochemical and physiological properties of a new fluorinated bile acid that prevents 17alpha-ethynyl-estradiol-induced cholestasis in rats.. 135
Integrated Fragment-Based Approaches on the Route to Novel IDO1 Modulators 130
Dexpramipexole blocks Nav1.8 sodium channels and provides analgesia in multiple nociceptive and neuropathic pain models 129
N-Decyl-S-trityl-(R)-cysteine, a new chiral selector for "green" ligand-exchange chromatography applications 129
New Insights from Crystallographic Data: Diversity of Structural Motifs and Molecular Recognition Properties between Groups of IDO1 Structures 128
Structure-activity relationships of bisphophonate nucleotide derivatives as P2Y1 receptor antagonists and partial agonists 127
6a-Ethyl-chenodeoxycholic acid (6-ECDCA), a potent and selective FXR agonist endowed with anticholestatic activity. 125
Enantioselective HPLC analysis to assist the chemical exploration of chiral imidazolines 125
2-Substituted N-ethylcarboxamidoadenosine derivatives as high-affinity agonists at human A3 adenosine receptors 122
Binding Mode of 6ECDCA, a Potent Bile Acid Agonist of the Farnesoid X Receptor (FXR) 122
Spiro[2.2]pentane as a Dissymmetric Scaffold for Conformationally Constrained Analogues of Glutamic Acid: Focus on Racemic 1-Aminospiro[2.2]pentyl-1,4-dicarboxylic Acids 120
Towards New Neuroprotective Agents: Design and Synthesis of Thieno[2,3-c]-isoquinolinon-5-one as a Potent PARP-1 Inhibitor. 117
1μs Molecular Dynamics Simulations to study the poisoning effect of the PARP-1 full length enzyme 115
Spiro[2.2]pentane as a dyssymetric scaffold for conformationally constrained analogues of glutamic acid: diastereodivergent synthesis of 1-aminospiro[2.2]pentyl-1,4-dicarboxylic acids 114
BF3·Et2O-Promoted Decomposition of Cyclic α-Diazo-β-Hydroxy Ketones: Novel Insights into Mechanistic Aspects 113
Metabotropic glutamate receptors: structure and new subtype-selective ligands 111
Circular Hazelnut Protection by Lignocellulosic Waste Valorization for Nanopesticides Development 111
Chiral separation of helical chromenes with chloromethyl phenylcarbamate polysaccharide-based stationary phases 110
On the way to selective PARP-2 inhibitors. Design, synthesis, and preliminary evaluation of a series of isoquinolinone derivatives. 109
Adenosine receptor agonists: Synthesis and biological evaluation of the diastereoisomers of 2-(3-hydroxy-3-phenyl-1-propyn-1-yl)NECA 109
Targeting the FXR nuclear receptor through a virtual screening approach 109
One Key and Multiple Locks: Substrate Binding in Structures of Tryptophan Dioxygenases and Hydroxylases 109
Preparation and use of nucleotide bisphosphate as P2Y antagonists 108
Adenosine deaminase inhibitors: synthesis and structure-activity relationships of 2-hydroxy-3-nonyl derivatives of azoles. 107
Fragment based drug design and diversity-oriented synthesis of carboxylic acid isosteres 107
Estimating the hydrophobicity extent of molecular fragments using reversed‐phase liquid chromatography 106
2-Alkenyl and 2-alkyl derivatives of adenosine and adenosine-5'-N-ethyluronamide: different affinity and selectivity of E- and Z-diastereomers at A2A adenosine receptors. 106
Design and synthesis of 4H-thieno[2,3-c]isoquinolin-5-one derivatives as potent PARP-1 inhibitors, on route of new antiischemic agents 106
Design, Molecular Modeling Studies, Synthesis and Preliminary Evaluation of Novel PARP-1 Inhibitors on the Road of Antiischemic Agents 105
Chromatographic hydrophobicity index: a high-throughput tool to estimate the critical micellar concentration of bile acids 105
PARP inhibitors: polypharmacology versus selective inhibition 105
Targeting Wnt-driven cancers: Discovery of novel tankyrase inhibitors 105
The relationship between s. Aureus and branched-chain amino acids content in composite cow milk 105
Selective PARP-2 inhibitors increase apoptosis in hippocampal slices but protect cortical cells in models of post-ischaemic brain damage 103
Novel PARP Inhibitors: Synthesis and Molecular Modeling Studies 100
Chiral ligand-exchange separation and resolution ofextremely rigid glutamate analogs: 1-aminospiro[2.2]pentyl-1,4-dicarboxylicacids. 100
6α-Ethyl-Chenodeoxycholic Acid (6-ECDCA), a Potent and Selective FXR Agonist Endowed with Anticholestatic Activity 100
Investigating the allosteric reverse signalling of PARP inhibitors with microsecond molecular dynamic simulations and fluorescence anisotropy. 100
Modeling of Poly(ADP-ribose)polymerase (PARP) Inhibitors. Docking of Ligands and QSAR 99
Adenosine Deaminase: Functional Implications and Different Classes of Inhibitors 99
2-Aralkynyl and 2-heteroalkynyl derivatives of adenosine-5'-N-ethyluronamide as selective A2a adenosine receptor agonists. 99
2-Alkynyl derivatives of adenosine-5'-N-ethyluronamide: selective A2 adenosine receptor agonists with potent inhibitory activity on platelet aggregation. 99
The Janus-faced nature of IDO1 in infectious diseases: Challenges and therapeutic opportunities 98
Recent advances in urea- and thiourea-containing compounds: focus on innovative approaches in medicinal chemistry and organic synthesis 98
Dexpramipexole improves bioenergetics and outcome in experimental stroke 96
Dual species sphingosine-1-phosphate lyase inhibitors to combine antifungal and anti-inflammatory activities in cystic fibrosis: a feasibility study 95
Rat Brain Guanosine Binding Site:Biological Studies and Pseudo Receptor Construction 95
Molecular recognition in P2 receptors: Ligand development aided by molecular modeling and mutagenesis 95
Pharmacology of the highly selective A1 adenosine receptor agonist2-chloro-N6-cyclopentyladenosine. 94
Adenosine deaminase inhibitors: Structure-activity relationships in 1-deazaadenosine and erythro-9-(2-hydroxy-3-nonyl)adenine analogues 94
Molecular docking and spatial coarse graining simulations as tools to investigate substrate recognition, enhancer binding and conformational transitions in indoleamine-2,3-dioxygenase (IDO). 93
Chiral ligand-exchange separation and resolution of extremely rigid glutamate analogues: 1-aminospiro[2.2]pentyl-1,4-dicarboxylic acids 93
A Green Nanostructured Pesticide to Control Tomato Bacterial Speck Disease 93
Rat brain guanosine binding site. Biological studies and pseudo-Receptor construction 92
Discovery and characterization of novel potent PARP-1 inhibitors endowed with neuroprotective properties: From TIQ-A to HYDAMTIQ 92
Investigating the allosteric reverse signalling of PARP inhibitors with microsecond molecular dynamic simulations and fluorescence anisotropy 92
Bile acids: property-activity relationship and molecular modelling studies 91
8-Bromo-9-etiladenine come tools per l’ottenimento di antagonisti selettivi per il recettore adenosinico A2B 91
Branched-chain amino acids as potential diagnostic and prognostic disease biomarkers 91
Boosting Immunity and Management against Wheat Fusarium Diseases by a Sustainable, Circular Nanostructured Delivery Platform 90
Adenosine deaminase inhibitors: synthesis, diastereoisomeric resolution and biological activity of 1-(2-hydroxy-3-nonyl)-1,2,4-triazole-3-carboxamide. 90
Highlights at the gate of tryptophan catabolism: a review on the mechanism of activation and regulation of indoleamine 2,3-dioxigenase (IDO), a novel target in cancer disease 89
Derived chromatographic indices as effective tools to study the self-aggregation process of bile acids 89
Effects of Molecular Dynamics and Replica Exchange Molecular Dynamics in Sampling the Conformational Space of PARP-1 89
Concepts and Molecular Aspects in the Polypharmacology of PARP-1 Inhibitors 88
Hydrophobic Amino Acid Content in Onions as Potential Fingerprints of Geographical Origin: The Case of Rossa da Inverno sel. Rojo Duro 88
Thymoquinone, a potential therapeutic agent of Nigella sativa, binds to site I of human serum albumin 87
Synthesis of New Nucleosides by coupling of chloropurines with 2- and 3-deoxy derivatives of N-methyl-D-ribofuranuronamide 87
Molecular determinats for metabotropic glutamate receptor activation and blockade. Molecular dynamics and electrostatic potential analysis studies 87
Multi-Gram Scale Synthesis and Characterization of Mometasone Furoate EP Impurity C 87
Insights in the PARP1 poisoning effect 86
Effects of new arylazido compounds of pyridoxal phosphate on ecto-ATPase activity of guinea pig tissues 85
Bile Acid Derivatives as Ligands of the Farnesoid X Receptor. Synthesis, Evaluation, and Structure Activity Relationship of a Series of Body and Side Chain Modified Analogs of Chenodeoxycholic Acid 85
The relationships between somatic cells and isoleucine, leucine and tyrosine content in cow milk 83
Pharmacological inhibition of poly(ADP-ribose) polymerase (PARP) activity in PARP-1 silenced tumour cells increases chemosensitivity to temozolomide and to a N3-adenine selective methylating agent 82
Quantitative analysis of cucurbitane-type triterpenes in Ibervillea sonorae extracts: Relationship study with their antiproliferative activity 82
Synthesis, molecular modelling and preliminary evaluation of a series of new thioidantoine derivatives as inhibitors of indoleamine-2,3-dioxygenase (IDO) 79
Synthesis and biological activity of 3'-deoxy derivative of adenosine (5'-N-methylcarboxamide) (MECA) 78
Poly(ADP-ribose) catabolism triggers AMP-dependent mitochondrial energy failure 77
Synthesis and Biological Evaluation of 2-(3’-(1H-tetrazol-5-yl)bicyclo[1.1.1]pent-1-yl)glycine (S-TBPG), a novel mGlu1 Receptor 76
Fast chromatographic determination of the bile salt critical micellar concentration 76
Synthesis and Receptor Affinity of Polysubstituted Adenosines 76
Dominant Factors Affecting the Chromatographic Behaviour of Bile Acids 75
HYDAMTIQ: A New, Potent PARP-1 Inhibitor with Neuroprotective Properties 75
Inhibitory Effects of 1-Deazaadenosine Analogues on HIV Replication and Adenosine Deaminase 75
Combined strategies toward the design and synthesis, of novel inhibitors of indoleamine-2,3-dioxygenase (IDO) 74
On the Way to Selective PARP-2 Inhibitors: Design, Synthesis and Preliminary Evaluation of a Series of Isoquinolinone Derivatives 74
Characterization of the novel poly(ADP-ribose) polymerase (PARP) inhibitor thieno[2,3-c]isoquinolin-5-one (TIQ): neuroprotective effects models of cerebral ischemia 74
Design, Synthesis, Crystallographic Studies and Preliminary Biological Appraisal of New Substituted Triazolo[4,3-b]pyridazin-8-amine Derivatives as Tankyrase Inhibitors. 74
Therapeutic Potential of a Novel Poly(ADP-ribose) Polymerase Inhibitor, Hydamtiq, in Human Pancreatic and Colon Cancers 74
Identification of the Nicotinamide Salvage Pathway as a New Toxification Route for Antimetabolites 74
Continuous Flow Synthesis of the PARP-1/2 Inhibitor HYDAMTIQ: Synthetic Strategy, Optimization, and Green Metrics Evaluation 73
Studies on the interaction between PARP’s catalytic site and inhibitors. Design and synthesis of new class of inhibitor derivatives 73
Towards Selective PARP-2 Inhibitors: Design, Synthesis and Preliminary Evaluation of a Series of Isoquinolinone Derivatives 72
Heterocycles as Companions on Route to Drug Discovery 72
Exploring the effect of PARP-1 flexibility in docking studies 72
Totale 9.859
Categoria #
all - tutte 63.610
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 63.610


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.181 0 212 11 54 37 11 13 405 43 51 138 206
2022/20232.058 165 391 30 121 178 215 3 83 760 7 76 29
2023/2024851 47 104 44 12 7 15 182 29 88 28 132 163
2024/20252.064 22 202 73 62 252 105 122 93 442 154 319 218
2025/20264.558 339 357 251 529 591 360 829 175 527 389 133 78
2026/2027191 102 89 0 0 0 0 0 0 0 0 0 0
Totale 13.579